RNA — Avidity Biosciences Share News
0.000.00%
Last trade - 00:00- $11.27bn
- $9.40bn
- $10.90m
Avidity rises as US FDA lifts partial clinical hold on genetic disease drug
U.S. RESEARCH ROUNDUP- First BanCorp, Kellanova, Popular
Brief: Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Avidity Biosciences Announces Closing Of Upsized Public Offering Of Common Stock
Brief: Avidity Biosciences Announces Pricing Of Upsized Public Of 7.3 Mln Shares At $41/Shr
Brief: Avidity Biosciences Intends To Offer And Sell $250 Mln Of Shares Of Common Stock In Underwritten Public Offering
Brief: Avidity Biosciences May Offer, Sell Shares Of Common Stock Of Up To $400 Mln
Avidity Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Brief: Avidity Biosciences Announces Positive Aoc 1044 Data Demonstrated Significant Increase Of 25% In Dystrophin Production And Reduction Of Creatine Kinase Levels To Near Normal In People Living With Duchenne Muscular Dystrophy Amenable To Exon 44 Skipping In The Phase 1/2 Explore44™ Trial
U.S. STOCKS ON THE MOVE-Gold miners, Hasbro, VinFast
Avidity Biosciences hits fresh record after upsized equity raise
Brief: Avidity Biosciences Announces Pricing Of Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP-Avidity Biosciences, Broadcom, Cara Therapeutics
Brief: Avidity Biosciences, Inc. Announces Proposed Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Tesla, Casey's General Store, Western Alliance
U.S. STOCKS ON THE MOVE-Tesla, Take-Two, Caterpillar
Avidity jumps on data from muscle disorder drug study
Brief: Avidity Biosciences Files For Mixed Shelf
U.S. STOCKS ON THE MOVE-Sigma Lithium, U.S Gold , Ballard Power